| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 8. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | calcium/colecalciferol (TheiCal-D3®) |
| Formulation | 1000 mg/880 IU chewable tablet |
| Reference number | 2412 |
| Indication | Prevention and treatment of vitamin D and calcium deficiency in the elderly. As vitamin D and calcium supplement as an adjunct to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency |
| Company | Stirling Anglian Pharmaceuticals Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 16/12/2013 |